4//SEC Filing
Turner William D. 4
Accession 0001193125-25-314156
CIK 0001831828other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:05 PM ET
Size
8.9 KB
Accession
0001193125-25-314156
Insider Transaction Report
Form 4
Turner William D.
Chief Development Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-08$15.53/sh+10,000$155,300→ 32,500 total - Sale
Class A Common Stock
2025-12-08$45.31/sh−10,000$453,053→ 22,500 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-08−10,000→ 255,000 totalExercise: $15.53Exp: 2034-01-04→ Class A Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001819688
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:05 PM ET
- Size
- 8.9 KB